Kynos Therapeutics

0 followers


Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.

Industries

+1

Employees

Links

Org chart

Jonathan Savidge
Chief Executive Officer

Jonathan Savidge

Collapse
Damian Mole
Chief Scientific Officer
David Brocklebank
Director, Clinical Operations
Scott Webster
Chief Technology Officer
Alison Strutt
Chief Financial Officer